Cite
HARVARD Citation
Deck, D. et al. (2016). Single-Dose Oritavancin Treatment of Acute Bacterial Skin and Skin Structure Infections: SOLO Trial Efficacy by Eron Severity and Management Setting. Infectious diseases and therapy. 5 (3), pp. 353-361. [Online].